iShares STOXX Europe 600 UCITS ETF (DE) (ETR:EXIE)
Germany · Delayed Price · Currency is EUR | Assets | 866.94M |
| Expense Ratio | 0.20% |
| PE Ratio | 18.46 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +15.09% |
| Volume | 193,900 |
| Open | 7.42 |
| Previous Close | 7.48 |
| Day's Range | 7.41 - 7.51 |
| 52-Week Low | 6.24 |
| 52-Week High | 7.65 |
| Beta | 1.01 |
| Holdings | 619 |
| Inception Date | Feb 23, 2023 |
About EXIE
iShares STOXX Europe 600 UCITS ETF (DE) is an exchange traded fund launched and managed by BlackRock Asset Management Deutschland AG. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap, mid-cap, and small-cap companies. It seeks to replicate the performance of the STOXX Europe 600 Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as iShares STOXX Europe 600 (DE). iShares STOXX Europe 600 UCITS ETF (DE) was founded on February 13, 2004 and is domiciled in Germany.
Performance
EXIE had a total return of 15.09% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.06%.
Top 10 Holdings
19.54% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 4.44% |
| HSBC Holdings plc | HSBA | 2.13% |
| Roche Holding AG | ROP | 1.84% |
| AstraZeneca PLC | AZN | 1.83% |
| Novartis AG | NOVN | 1.81% |
| Nestlé S.A. | NESN | 1.67% |
| Shell plc | SHEL | 1.66% |
| Siemens Aktiengesellschaft | SIE | 1.59% |
| TotalEnergies SE | TTE | 1.31% |
| Schneider Electric S.E. | SU | 1.26% |